Skip to main content

KKR sells 2.88% stake in CG Power, Jwalamukhi Investment offloads 2% in Ceat

 KKR India was the third seller in CG Power this week.

KKR India, a non-deposit taking NBFC, along with its debt fund, sold 2.88 percent equity stake in CG Power and Industrial Solutions on August 21 via open market transactions.

KKR India Debt Opportunities Fund II sold 34,64,021 equity shares in company at Rs 16.95 per share on the BSE, while KKR India Financial Services offloaded 50 lakh shares at same price on the BSE and 96,10,588 shares at Rs 16.85 per share on the NSE, bulk deals data available on the exchanges showed.

KKR India Debt Opportunities Fund II held 1,19,38,021 equity shares in CG Power (representing 1.91 percent of total paid up equity) and KKR India Financial Services had 5,07,36,588 shares or 8.10 percent stake in the company as of June 2020.

KKR India was the third seller in CG Power this week. Yes Bank on August 19 said it exited CG Power by selling entire shareholding in company. Yes Bank held 12.79 percent stake in CG Power as of June 2020.

L&T Finance also exited the company on August 17 by selling its entire 10 percent stake in two deals. But the stock consistently gained throughout this week, rising 27.3 percent in the week ended August 21.

Among other deals, Jwalamukhi Investment Holdings, an investment subsidiary of private equity company Westbridge Capital, offloaded 2 percent equity stake in Ceat via two bulk deals on August 21.


Jwalamukhi sold 3,49,332 equity shares in company at Rs 871.28 per share on the BSE and 4,88,249 shares at Rs 871.24 per share on the NSE. As of June 2020, it held 23,33,991 shares (representing 5.77 percent of the total paid up equity) in company.

ICICI Prudential Mutual Fund acquired 9.5 lakh shares in Sudarshan Chemical Industries (1.37 percent of total paid up equity) at Rs 430.05 per share, whereas Rohit Kishor Rathi sold 10 lakh shares (1.44 percent of total paid up equity) at Rs 430.16 per share on the BSE.

Follow Us On Facebook- Click Here

Rohit Kishor Rathi held 6 percent equity stake in Sudarshan Chemical Industries as of June 2020.

Investor Porinju Veliyath-owned Equity Intelligence India acquired additional 80,000 shares in Orient Bell at Rs 91.87 per share on the NSE. The stock rallied 7 percent today.

Equity Intelligence India already held 2,25,000 shares or 1.57 percent stake in company as per June 2020's shareholding pattern.

Clix Capital Services sold another 1.64 crore shares in Future Consumer at Rs 10.74 per share on the NSE today, after selling 1.11 crore shares in previous session.

Aviator Global Investment Fund bought 33.5 lakh shares in Vikas Multicorp at Rs 16.70 per share on the BSE and Plutus Wealth Management LLP acquired 3.15 lakh shares in BASF at Rs 1,584.46 per share on the NSE.

Asian Agro Industries sold 1.48 lakh shares in Asian Hotels (North) at Rs 63.91 per share on the NSE and Thakar Ashish Bhupendra sold 1.8 lakh shares in GSS Infotech at Rs 27.15 per share on the NSE.

Environment Agency Active Pension Fund offloaded 4,02,933 shares in VA Tech Wabag at Rs 207.59 per share on the NSE, but the stock rallied 19 percent today.

New World Capital bought 1.3 lakh shares in Flexituff Ventures International at Rs 7.9 per share, whereas Clearwater Capital Partners Singapore Fund IV sold 3.77 lakh shares at same price on the NSE.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more